PLIVA 787 (Azithromycin monohydrate 250 mg)
Pill imprint PLIVA 787 has been identified as Azithromycin monohydrate 250 mg.
Azithromycin is used in the treatment of chlamydia infection; bacterial infection; bronchitis; upper respiratory tract infection; tonsillitis/pharyngitis (and more), and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy. Azithromycin 250 mg is not subject to the Controlled Substances Act.
See also related documents.
- 250 mg
- 15.00 mm
- Elliptical / Oval
- Prescription only
calcium phosphate dibasic anhydrous
hypromellose 2910 (15 mPa.s)
polyethylene glycol 4000
trisodium citrate dihydrate
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|58016-0086||Southwood Pharmaceuticals Inc (repackager)|
|16590-0362||Stat RX USA LLC (repackager)|
|55887-0785||Diversified Healthcare Services Inc (repackager)|
|18837-0338||Innoviant Pharmacy Inc (repackager)|
|43063-0090||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about azithromycin
- Azithromycin single-dose packet
- Azithromycin suspension
- Azithromycin tablets
- Azithromycin (Advanced Reading)
- Azithromycin Intravenous (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.